This suggests that DC therapy might be helpful for autoimmunity of patients with abnormal Fas expression on the immune cells, and that a therapy for autoimmunity using normal DCs might fail to prevent or treat autoimmune diseases. The gene discussed is FAS; the disease is Autoimmunity.